Target Protein Degradation Market is projected to be over USD 3

  • The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago.

    Presently, a variety of other such chemical entities and molecular glues are under investigation. In fact, certain pipeline candidates are already in the mid to late-phase trials and are anticipated to soon enter the market.

    The USD 3.6 billion (by 2030) financial opportunity within the Target Protein Degradation Market has been analyzed across the following segments:

    Type of payment of licensing agreements

    • Upfront payments
    • Milestone payments

    Type of protein degrader

    • Degronimids
    • PROTACs
    • SARDs / SERDs
    • Specific BET and DUB inhibitors
    • Other protein degraders

    Therapeutic area

    • Neurodegenerative disorders
    • Oncological disorders
    • Other therapeutic areas

    Route of administration 

    • Oral
    • Intravenous
    • Other routes

    Key geographical region

    • North America
    • Europe
    • Asia-Pacific

    The Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030 report features the following companies, which we identified to be key players in this domain:

    Get detailed Analysis:

    Key Players

    • Arvinas
    • Captor Therapeutics
    • Celgene
    • Genetech
    • Kymera Therapeutics
    • Mission Therapeutics
    • Progenra
    • Radius Health
    • Sanofi Genzyme
    • Zenopharm

    Table of Contents

    1. Preface
    2. Executive Summary
    3. Introduction
    4. Current Market Landscape
    5. Company Profiles
    6. Clinical Trial Analysis
    7. KOL Analysis
    8. Publication Analysis
    9. Funding and Investment Analysis
    10. Partnerships and Collaborations
    11. Market Sizing and Opportunity Analysis
    12. Executive Insights
    13. Concluding Remarks
    14. Appendix 1: Tabulated Data
    15. Appendix 2: List of Companies and Organizations

    Get Customized Report:

    About Roots Analysis

    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.

    Contact Information

    Roots Analysis Private Limited

    Gaurav Chaudhary

    +1 (415) 800 3415


    Also Visit Our Latest Publication:

    Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market

    CAR-T Cell Therapies Market

    Patient Recruitment and Retention Services Market

    mRNA Therapeutics and Vaccines Market

    T-Cell (CAR-T, TCR, and TIL) Therapies Market